The funds will be deployed towards brand building, launching RxMen-branded products and setting up co-branded clinics
Delhi-based Men’s health tech platform, RxMen has raised Rs 5 crore in a seed round led by Inflection Point Ventures, one of India’s largest Angel investing platforms. With this funding, RxMen aims to achieve a positive EBITDA by October 2025. In addition, the funds will be used for brand building, launching RxMen-branded products and setting up co-branded clinics. The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures and received a grant from the Prosus Group.
Vinay Bansal, Founder, IPV adds, “Often men’s issues related to sexual health, skin and hair are overlooked. Add to it the stigma of discussing such issues publicly makes it very difficult for Indian men to access good quality healthcare and get treatment for their problems. RxMen provides an all in one men’s health platform designed specifically for their needs which addresses these issues in a holistic manner. By offering solutions to challenges that are typically neglected and rarely spoken about, RxMen empowers men to normalize these issues and tackle them with confidence.”
Shailja Mittal, Founder and CEO, RxMen said, “At RxMen, our focus has always been on building a clinical, root-cause platform for men’s health. This fundraiser helps us strengthen that mission, expanding care beyond sexual health into stress, sleep, hair, skin, and weight, and continue creating a credible ecosystem where men can finally access the right treatment and support.”
